Tenet Healthcare (THC) Gets a Buy Rating from Raymond James
In a report released yesterday, John Ransom from Raymond James maintained a Buy rating on Tenet Healthcare (THC), with a price target of $37. The company’s shares opened today at $26.92.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 9.6% and a 61.9% success rate. Ransom covers the Services sector, focusing on stocks such as Service Corp International, Acadia Healthcare, and UnitedHealth.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $31.36 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $39.74 and a one-year low of $12.45. Currently, Tenet Healthcare has an average volume of 1.24M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.